NCT07714187
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,646 public trials
848 recruiting studies
Lymphoma trial results
Not Yet Recruiting
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
NCT07712588
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- Hunan Cancer Hospital Changsha, Hunan, China
- Cancer Hospital of Shandong Frist Medical University Jinan, Shangdong, China
Not Yet Recruiting
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
NCT07711327
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
- Locations
-
- City of Hope Duarte, California, United States
- UC San Diego Health San Diego, California, United States
- Stanford Health Care Stanford, California, United States
Not Yet Recruiting
Pre-emptive Anakinra for Cytokine Event Reduction
NCT06703216
- Conditions
- B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
- Locations
-
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
Not Yet Recruiting
New Genotype-guided Treatment in Newly Diagnosed PTCL
NCT07706959
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
NCT07164469
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +8 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma
NCT07705308
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
- Fudan University Affiliated Minhang Hospital Shanghai, Shanghai Municipality, China
- Huadong Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP
NCT07702851
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
Not specified
Not Yet Recruiting
HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell Lymphoma
NCT07697339
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
NCT07254793
- Conditions
- Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia (AUL), +31 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States